Wells Fargo
SILO icon

Wells Fargo’s Silo Pharma SILO Stock Holding History

Wells Fargo’s Portfolio SILO Stock Details SILO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$4 – 7565
2026
Q1 		$4 Hold
1
– – ﹤0.01% 7052
2025
Q4 		$3 Hold
1
– – ﹤0.01% 7007
2025
Q3 		$7 Buy
+1
New +$10 ﹤0.01% 6896
2024
Q2 		– Sell
-1
Closed -$33 – 7403
2024
Q1 		$33 Hold
1
– – ﹤0.01% 6961
2023
Q4 		$29 Hold
1
– – ﹤0.01% 7084
2023
Q3 		$32 Hold
1
– – ﹤0.01% 7041
2023
Q2 		$43 Hold
1
– – ﹤0.01% 7097
2023
Q1 		$42 Hold
1
– – ﹤0.01% 7159
2022
Q4 		$64 Buy
+1
New +$59 ﹤0.01% 6928

Other funds holding SILO

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wells Fargo's SILO Position: Q2 2026 in Review

Wells Fargo sold out of Silo Pharma (SILO) in Q2 2026, closing a stake of 1 share — an estimated $4 sold.

Wells Fargo first reported a position in SILO in Q4 2022 and held it in 9 quarters. The position peaked at $64 in Q4 2022. 9 funds tracked by Wall St. Rank hold SILO as of Q2 2026.

  • Wells Fargo reported no remaining Silo Pharma position as of Q2 2026 after selling out during the quarter.
  • Wells Fargo sold 1 Silo Pharma share in Q2 2026, an estimated $4.
  • Wells Fargo first reported a position in Silo Pharma in Q4 2022 and held it in 9 quarters.
  • Wells Fargo's Silo Pharma position peaked at $64 in Q4 2022.
  • 9 funds tracked by Wall St. Rank held Silo Pharma as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.